Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Clinical trial NCT05819359 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05819359
- Sponsor
- Bial R&D Investments, S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2026-04-02
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.